流感抗原现货库存：

09/274  Influenza Virus Infectious NYMC X-185
98/762  Influenza Virus infectious Resvir-14 (H3N2)
90/784  Influenza Virus infectious NIB-26 (H3N2)
05/102  Influenza Virus infectious NYMC BX-7
12/202  Influenza virus infectious NYMC BX-39
00/530  Influenza Virus infectious B/Sichuan/379/99
05/138  Influenza Virus infectious B/Shanghai/361/2002
12/202  Influenza virus infectious NYMC BX-39
13/116  Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
92/734  Influenza Virus infectious A/Beijing/32/92 (H3N2)
92/738  Influenza Virus infectious A/Shanghai/24/90
93/568  Influenza Virus infectious A/Beijing/359/89 (H3N2)
93/572  Influenza Virus infectious A/Guizhou/54/89 (H3N2)
93/686  Influenza Virus infectious A/Shangdong/9/93 (H3N2)
95/758  Influenza Virus infectious A/Wuhan/359/95 (H3N2)
98/778  Influenza Virus infectious A/Sichuan/346/98 (H3N2)

其他抗原抗体库存：

97/648  Anti-Measles serum
RAI     Anti-rabies Immunoglobulin, Human
83/575  Follicle Stimulating Hormone, Pituitary
06/166  Antithrombin Concentrate, Human
90/636  HIV-1 P24 Antigen
08/258  Antithrombin, Plasma (3rd International Standard)

13/242  FEIBA Concentrate 2nd NIBSC Working Reference Standard
92/680  Serum amyloid A protein. WHO International Standard
92/644  Interleukin-1 receptor antagonist (Human rDNA derived)
05/112  Low Molecular Weight Heparin for Molecular Weight Calibration(2nd International Standard)
08/282  Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
10/266  4th WHO International Standard for HBV DNA for NAT
14/150  Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)
13/146  C-Peptide, Human. 1st International Standard
93/556  Nerve Growth Factor (Human, rDNA derived)
16/194  HIV-1 RNA 4th International Standard
AFP(72/225)  Alpha-Foetoprotein
83/500  Insulin, Human
09/296  1st International Standard for human Proinsulin
83/573(84/500)  Prolactin, Human
96/668  Prostate-Specific Antigen Free
10/152  Candidate HIV-1 RNA 3rd International Standard
PPDBOV  Purified Protein Derivative (PPD) of Bovine Tuberculin WHO International Standard
PPDA  Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
67/182  Anti-Rubella Serum, Human
12/226  HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
93/526  Batroxobin
10/266 (10/264)  Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
07/164  Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
09/260  Epstein-Barr Virus (1st International Standard)
B2M  Beta-2 Microglobulin
75/595  Blood Coagulation Factor Xa, Bovine
13/100  Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
12/224  HIV-1 NAT subtypes (Main)(2nd International Reference Preparationl)
14/290  4th HCV RNA Genotype Panel for Nucleic Acid Amplification
11/234(75/502)  Serum Immunoglobulin E (IgE) Human
88/646  Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
87/640  Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
85/506  C-Reactive Protein, Human
92/510  Follicle Stimulating Hormone, Human, recombinant
08/258  Antithrombin, Plasma (3rd International Standard)
66/387  Anti-thyroid Microsome Serum, Human
06/202  HPV 16 DNA
06/206  HPV 18 DNA
94/572  Ferritin, Human, recombinant
RTF/16  Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016
83/575  Follicle Stimulating Hormone, Pituitary
73/601  Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
RAI  Anti-rabies Immunoglobulin, Human
80/505  Growth Hormone, Human, Pituitary
RUBI-1-94  Anti-rubella Immunoglobulin, Human
75/551  Chorionic Gonadotrophin beta Subunit, Human
09/162  Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard
81/535(80/552)  Luteinizing Hormone, Human, Pituitary
91/530  Epidermal Growth Factor (Human, rDNA derived)
09/264  Fibrinogen Plasma (D)(3rd International Standard)

NIBSC 标准品

Biotherapeutics
Cytokines and Growth Factors 
Endotoxin 
Haemostasis 
Immunogenicity 
Immunoglobulins and immune sera 
Protein Hormones and Endocrine Products 
Quality Control Reagent

UK Stem Cell Bank 
Mouse Embryo Fibroblasts

Diagnostics
Allergen 
Anti-Toxins 
Blood borne pathogens 
Blood Transfusion and Transplantation 
Ebola Virus 
Genomic Reference Material 
Haematinics and Haemoglobin 
Haemostasis 
Human Papillomavirus 
Immunoglobulins and immune sera 
Miscellaneous 
Parasitology 
Parvovirus 
Protein Hormones and Endocrine Products 
Quality Control Reagent 
Zoonosis and livestock diseases

Vaccines
Botulinum 
Clostridium 
Diphtheria 
Ebola Virus 
Enteric disease 
Haemophilus Influenzae type b (Hib) 
Human Papillomavirus 
Influenza 
JE/Dengue 
Malaria 
Meningococcal typing and ELISA reagents 
MMR 
Parasitology 
Pertussis 
Pneumococcal vaccines 
Polio 
Quality Control Reagent 
Staphylococcal Immune Sera 
Tetanus 
Tuberculosis 
Vaccinia 
Yellow Fever 
Zoonosis and livestock diseases

02/144 Anti-Meningococcal Serosubtype P1.15 mAb
Non WHO Reference Material 
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
Non WHO Reference Material 
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
WHO International Standard 
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
Non WHO Reference Material 
02/180 Anti-Meningococcal Serotype P2.2a mAb
Non WHO Reference Material 
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
Non WHO Reference Material 
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
Non WHO Reference Material 
02/206 Factor XIII Plasma, Human (1st International Standard)
WHO International Standard 
02/210 HIV (antibody), 1st International Reference Panel
International Reference Preparation 
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
International Reference Reagent 
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
International Reference Reagent 
02/230 Biotinylated Brad-5 (Bio-Brad-5)
Working Standard 
02/232 Tetanus Toxoid (Non-Adsorbed)
Non WHO Reference Material 
02/254 Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)
WHO International Standard 
02/262 Influenza Virus infectious B/Brisbane/32/2002
Influenza Reagent 
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
International Reference Reagent 
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
Influenza Reagent 
02/308 Anti-Meningococcal Serotype P3.4 mAb
Non WHO Reference Material 
02/310 Anti-Meningococcal Serotype P3.15 mAb
Non WHO Reference Material 
02/318 Botulinum Antitoxin Equine Type E
Non WHO Reference Material 
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
Non WHO Reference Material 
02/336 Influenza Antigen A/New Caledonia/20/99
Influenza Reagent 
02/338 Influenza anti A/Panama/2007/99 Serum
Influenza Reagent 
02/342 Protein C Plasma, Human(2nd International Standard)
WHO International Standard 
03/104-018 HTLV-1 (antibody) Monitor Sample
CE Marked Material 
03/110 Influenza anti B/Shangdong/9/97 Serum
Influenza Reagent 
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
Non WHO Reference Material 
03/116 Blood Coagulation Factor V, Plasma Human (1st International Standard)
WHO International Standard 
03/124 Thrombopoietin ( Human rDNA derived)
Non WHO Reference Material 
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
Non WHO Reference Material 
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
International Reference Reagent 
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
International Reference Reagent 
03/152 Anti-HPA-1a (International Standard)
WHO International Standard 
03/164 Anti-B minimum potency reference preparation(International Standard)
WHO International Standard 
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
WHO International Standard 
03/182 Anti-Meningococcal Serotype P3.21 mAb
Non WHO Reference Material 
03/188 Anti-A minimum potency reference preparation(International Standard)
WHO International Standard 
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
International Reference Reagent 
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
WHO International Standard 
03/198 Influenza Virus infectious A/Kumamoto/102/02
Influenza Reagent 
03/200 Interleukin - 18 (Human rDNA derived)(International Reference Reagent)
International Reference Reagent 
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
Non WHO Reference Material 
03/212 Influenza anti A/Wyoming/03/03 Serum
Influenza Reagent 
03/220 Influenza Antigen A/Wyoming/03/03
Influenza Reagent 
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
Non WHO Reference Material 
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
Non WHO Reference Material 
03/228 Protein S, Plasma, Human(2nd International Standard)
WHO International Standard 
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
Non WHO Reference Material 
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
Influenza Reagent 
03/244 Influenza Antiserum A/chick/Germany/N/49
Influenza Reagent 
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
Influenza Reagent 
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
International Reference Preparation 
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
Non WHO Reference Material 
04/132 IVIG + Anti-D for use with negative control IVIG
Non WHO Reference Material 
04/140 IVIG Negative Control for use with IVIG & Anti-D
Non WHO Reference Material 
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
WHO International Standard 
04/160 Influenza Virus infectious NYMC X-147
Influenza Reagent 
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
WHO International Standard 
04/170 Influenza Virus infectious A/Wellington/1/2004
Influenza Reagent 
04/172 Influenza Virus infectious IVR-139
Influenza Reagent 
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
WHO International Standard 
04/198 Anti-Meningococcal Serotype P3.1 mAb
Non WHO Reference Material 
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
WHO International Standard 
04/202 Influenza Antigen B/ Jiangsu/10/2003
Influenza Reagent 
04/214 Influenza Antiserum A/Viet Nam/1194/04 (H5N1)
Influenza Reagent 
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
WHO International Standard 
04/228 Influenza anti B/ Neuraminidase Serum
Influenza Reagent 
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum
Influenza Reagent 
04/246 Anti-Meningococcal Serogroup W-135 mAb
Non WHO Reference Material 
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
Non WHO Reference Material 
04/252 Protein C Concentrate, Human(1st International Standard)
WHO International Standard 
04/260 Influenza anti A/New Caledonia/20/99 HA Serum
Influenza Reagent 
04/262 Influenza anti A/New York/55/2004 HA Serum
Influenza Reagent 
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
Influenza Reagent 
05/102 Influenza Virus infectious NYMC BX-7
Influenza Reagent 
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
International Reference Reagent 
05/110 Influenza Virus infectious A/California/7/2004
Influenza Reagent 
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
WHO International Standard 
05/122 Syphilitic plasma IgG (human)(1st International Standard)
WHO International Standard 
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
WHO International Standard 
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
WHO International Standard 
05/138 Influenza Virus infectious B/Shanghai/361/2002
Influenza Reagent 
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
WHO International Standard 
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
Non WHO Reference Material 
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
Non WHO Reference Material 
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
Influenza Reagent 
05/236 Influenza anti A/Wisconsin/67/2005 Serum
Influenza Reagent 
05/242 IVIG, Anti-D and Negative Control Panel
Non WHO Reference Material 
05/252 Influenza anti B Neuraminidase Serum
Influenza Reagent 
06/108 Influenza Virus infectious IVR-116
Influenza Reagent